Skip to main content

The business of clinical trials is booming. Private equity has taken notice.

By Kaiser Health News  
   December 02, 2022

Private equity firms have moved aggressively into the healthcare industry's more hidden niches: They are pouring billions into the business of clinical drug trials.

Full story

Get the latest on healthcare leadership in your inbox.